CVS Health (CVS) Tops Q3 EPS by 20c, Lifts FY EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads gains as SpaceX, Super Micro results improve AI appetite
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
Tweet
Share
E-mail
Get Alerts CVS Hot Sheet
Price: $94.17 -0.61%
EPS Growth %: +3.1%
Financial Fact:
Net income: 1.54B
Today's EPS Names:
OMID, BCML, CZNC, More
EPS Growth %: +3.1%
Financial Fact:
Net income: 1.54B
Today's EPS Names:
OMID, BCML, CZNC, More
Join SI Premium – FREE
CVS Health (NYSE: CVS) reported Q3 EPS of $1.97, $0.20 better than the analyst estimate of $1.77. Revenue for the quarter came in at $73.79 billion versus the consensus estimate of $70.4 billion.
GUIDANCE:
CVS Health sees FY2021 EPS of $7.90-$8.00, versus the consensus of $7.79.
For earnings history and earnings-related data on CVS Health (CVS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Netflix shares fall over 5% premarket on soft current-quarter revenue guidance
- Abbott (ABT) Reports In-Line Q3 EPS
- M/I Homes (MHO) Misses Q3 EPS by 55c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
